BRCA1, BRCA2, and Associated Cancer Risks for Male Patients
Yüksel Ürün shared on X about a recent paper by Heather Cheng et al. titled “BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients” published in JAMA Oncology.
Authors: Heather H. Cheng,Jeffrey W. Shevach, Elena Castro et al.
“BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients Half of BRCA1/2 carriers are male, yet their health risks are often overlooked.
These males face higher risks of prostate, pancreatic, and breast cancers. Increased genetic testing in males is crucial for early detection, targeted treatment, and reducing family cancer risk.”
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023